About
Cognition Therapeutics Inc (NASDAQ:CGTX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 7 2026
Cognition Therapeutics to Present at Needham Virtual Healthcare Conference
Mar 26 2026
Cognition Therapeutics Reports Year End 2025 Financial Results and Provides Clinical Development Update
Mar 23 2026
Cognition Therapeutics to Report Fourth Quarter and Year End 2025 Financial Results
Mar 17 2026
Cognition Therapeutics Presents Evidence of Zervimesine’s Impact on Neuropsychiatric Symptoms of Dementia with Lewy Bodies at AD/PD 2026
Mar 2 2026
Cognition Therapeutics Advancing Zervimesine (CT1812) for Dementia with Lewy Bodies (DLB) Psychosis
Financials
Revenue
$0
Market Cap
$77.56 M
EPS
-0.32
Google Übersetzer